Efficacy of controlled-release niacin in treatment of metabolic syndrome: Correlation to surrogate markers of atherosclerosis, vascular reactivity, and inflammation
To access this article, please choose from the options below
Corresponding author.
PII: S1933-2874(07)00284-X
doi:10.1016/j.jacl.2007.10.002
© 2007 National Lipid Association. Published by Elsevier Inc. All rights reserved.
